Adaptimmune Therapeutics Correlations
ADAP Stock | USD 0.22 0.01 4.35% |
The current 90-days correlation between Adaptimmune Therapeutics and Black Diamond Therapeutics is -0.1 (i.e., Good diversification). The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Adaptimmune Therapeutics Correlation With Market
Average diversification
The correlation between Adaptimmune Therapeutics Plc and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and DJI in the same portfolio, assuming nothing else is changed.
Adaptimmune |
Moving together with Adaptimmune Stock
0.76 | CDIOW | Cardio Diagnostics | PairCorr |
0.69 | SCLX | Scilex Holding | PairCorr |
0.73 | ASMB | Assembly Biosciences | PairCorr |
0.68 | CMND | Clearmind Medicine Common | PairCorr |
0.71 | HD | Home Depot | PairCorr |
0.77 | DIS | Walt Disney | PairCorr |
0.65 | MSFT | Microsoft | PairCorr |
Moving against Adaptimmune Stock
0.62 | LUCD | Lucid Diagnostics | PairCorr |
0.49 | WM | Waste Management | PairCorr |
0.41 | GE | GE Aerospace | PairCorr |
0.76 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
0.65 | JNJ | Johnson Johnson | PairCorr |
0.65 | T | ATT Inc Aggressive Push | PairCorr |
0.65 | CVX | Chevron Corp | PairCorr |
0.47 | INTC | Intel | PairCorr |
0.45 | MMM | 3M Company | PairCorr |
0.34 | IBM | International Business | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adaptimmune Stock performing well and Adaptimmune Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adaptimmune Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
STOK | 3.48 | (0.51) | 0.00 | (0.29) | 0.00 | 7.03 | 20.29 | |||
FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
BDTX | 3.90 | (0.46) | 0.00 | (0.24) | 0.00 | 7.09 | 29.04 | |||
HARP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MREO | 2.68 | (0.44) | 0.00 | (0.54) | 0.00 | 6.16 | 20.77 | |||
PIRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PDSB | 4.46 | (0.40) | 0.00 | (0.40) | 0.00 | 9.21 | 33.91 | |||
LPTX | 4.79 | (1.88) | 0.00 | (5.23) | 0.00 | 5.88 | 82.92 | |||
AFMD | 2.56 | (0.58) | 0.00 | (1.23) | 0.00 | 5.10 | 23.29 | |||
CRVS | 3.65 | (0.42) | 0.00 | (0.37) | 0.00 | 7.37 | 17.12 |
Adaptimmune Therapeutics Corporate Management
Kerry Sharp | Senior Council | Profile | |
Dennis Williams | Senior Development | Profile | |
Sbastien Desprez | VP Affairs | Profile | |
Dana Lynch | Senior Communications | Profile | |
Helen MBA | CoFounder Officer | Profile | |
Bertrand Esq | Chief Officer | Profile |